A double-blind, placebo-controlled study of tacrine in patients with Alzheimer's disease using SPET

Journal of Psychopharmacology

Volumn 10, Issue 3, 1996, Pages 175-181

  Prentice, Neil ^a   Van Beck, Margaret ^a   Dougall, Nadine J ^a   Moffoot, Anthony P R ^a   O'Carroll, Ronan E ^a   Goodwin, Guy M ^a   Ebmeier, Klaus P ^a  

^a ROYAL EDINBURGH HOSPITAL   (United Kingdom)

Author keywords

Alzheimer's disease; Double blind treatment; Tacrine

Indexed keywords

CHOLINESTERASE INHIBITOR; TACRINE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN PERFUSION; CHOLINERGIC SYSTEM; CINGULATE GYRUS; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; OCCIPITAL CORTEX; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL CORTEX; VERBAL BEHAVIOR;

EID: 0029777453     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988119601000301     Document Type: Article

References (43)

1. American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, 3rd edn, revised. American Psychiatric Association, Washington, DC
2. Bassant MH, Jazatpoindessous F (1995) Metabolic response to tacrine (THA) and physostigmine in the aged rat brain. J Cereb Blood Flow Metab 15: 1093-1102
3. Bassant MH, Jazat F, Lamour Y (1993) Tetrahydroaminoacridine and physostigmine increase cerebral glucose utilization in specific cortical and subcortical regions in the rat. J Cereb Blood Flow Metab 13: 855-864
4. Borkowski JG, Benton AL, Spreen O (1967) Word fluency and brain damage. Neuropsychologia 5: 135-140
5. Burns A, Philpot MP, Costa DC, Ell PJ, Levy R (1989) The investigation of Alzheimer's disese with single photon emission tomography. J Neurol Neurosurg Psychiatr 52: 248-253
6. Chatellier G, Lacomblez L (1990) Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Br Med J 300: 485-499
7. Crow TJ, Grove-White IG (1973) An analysis of the learning deficit following hyoscine administration to man. Br J Pharmacol 49: 322-327
8. Curran SM, Murray CM, Van Beck M, Dougall N, O'Carroll RE, Austin M-P, Ebmeier KP, Goodwin GM (1993) A single photon emission computerised tomography study of regional brain function in elderly patients with major depression and with Alzheimer-type dementia. Br J Psychiatr 163: 155-165
9. Davis KL, Thal LJ, Gamzu ER, Davis CS, Woolson RF, Gracon SI, Drachman DA, Schneider LS, Whitehouse PJ, Hoover TM, Morris JC, Kawas CH, Knopman DS, Earl NL, Kumar V, Doody RS (1992) A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. New Engl J Med 327: 1253-1259
10. Eagger SA, Levy R, Sahakian BJ (1991) Tacrine in Alzheimer's disease. Lancet 337: 989-992
11. Ebmeier KP, Besson JAO, Crawford JR, Palin AN, Gemmell HG, Sharp PF, Cherryman GR, Smith FW (1987) Nuclear magnetic resonance imaging and single photon emission tomography with radio-iodine labelled compounds in the diagnosis of dementia. Acta Psychiatr Scand 75: 549-556
12. Ebmeier KP, Dougall NJ, Austin M-P, Murray CL, Curran SM, O'Carroll R, Moffoot APR, Hannan J, Goodwin GM (1991) The split-dose technique for the study of psychological and pharmacological activation with the cerebral blood flow marker exametazime and single photon emission computed tomography (SPECT): reproducibility and rater reliability. Int J Meth Psychiatr Res 1: 27-38
13. Ebmeier KP, Hunter R, Curran SM, Dougall NJ, Murray CL, Wyper DJ, Patterson J, Hanson MT, Siegfried K, Goodwin GM (1992) Effects of a single dose of the acetylcholinesterase inhibitor velnacrine on recognition memory and regional cerebral blood flow in Alzheimer's disease. Psychopharmacology 108: 103-109
14. Farlow M, Gracon SI, Hershey LA, Lewis KW, Sadowsky C, Dolan-Ureno J (1992) A controlled trial of tacrine in Alzheimer's disease. J Am Med Assoc 268: 2523-2529
15. Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198
16. Forsyth DR, Wilcock GK, Morgan RA, Truman CA, Ford JM, Roberts CJC (1989) Pharmacokinetics of tacrine hydrochloride in Alzheimer's disease. Clin Pharmacol Ther 46: 634-641
17. Fox PT, Raichle ME (1986) Focal physiological uncoupling of cerebral blood flow and oxidative metabolism during somatosensory stimulation in human subjects. Proc Natl Acad Sci USA 83: 1140-1144
18. Freeman SE, Dawson RM (1991) Tacrine: a pharmacological review. Prog Neurobiol 36: 257-277
19. Gauthier S, Bouchard R, Lamontagne A, Bailey P, Bergman H, Ratner J, Tesfaye Y, Saint-Martin M, Bacher Y, Carrier L, Charbonneau R, Clarkfield AM, Collier B, Dastoor D, Gauthier L, Germain M, Kissel C, Krieger M, Kushnir S, Masson H, Morin J, Nair V, Neirinck L, Suissa S (1990) Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease. New Engl J Med 322: 1272-1276
20. Geaney DP, Soper N, Shepstone BJ, Cowen PJ (1990) Effect of central cholinergic stimulation on regional cerebral blood flow in Alzheimer disease. Lancet 335: 1484-1487
21. Heft F, Schneider LS (1989) Rationale for the planned trials with nerve growth factor in Alzheimer's disease. Psychiatr Devel 7: 297-315
22. 99mTc-HMPAO in patients with presenile Alzheimer's disease and Korsakoff's psychosis. Psychol Med 19: 847-355
23. Hunter R, Wyper DJ, Patterson J, Hansen MT, Goodwin GM (1991) Cerebral pharmacodynamics of physostigmine in Alzheimer's disease investigated using single-photon computerised tomography. Br J Psychiatr 158: 351-357
24. Jacoby RJ, Levy R (1980) Computed tomography in the elderly 2. Senile dementia: diagnosis and functional impairment. Br J Psychiatr 136: 256-269
25. Jobst KA, Smith AD, Szatmari M, Molyneux A, Esiri ME, King E, Smith A, Jaskowski A, McDonald B, Wald N (1992) Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomography. Lancet 340: 1179-1183
26. Knapp MJ, Knopman DS, Solomon PR, Pendlebury WW, Davis CS, Gracon SI, Apter JT, Lazarus CN, Baker KE, Barnett M, Baumel B, Eisner LS, Castells B, Bolouri R, Bennett D, Forchetti C, Levin A, Blass JP, Nolan KA, Gaines ER, Relkin N, Borison RL, Diamond B, Celesia GG, Ross AP, Dexter J, Doody R, Lipscomb L, Kreiter K, Duboff EA, Block P, Marshall D, Westergaard N, Earl NL, Wyne SV, Hinmansmith E, Farlow M, Hendrie HC, Caress JA, Farmer M, Harper JE, Ferguson J, Foster NL, Barbas NR, Bluemlein LA, Gelb DJ, Berent S, Giordani B, Greenwald M, Bergman S, Roger LF, Groenendyk A, Wood M, Jurkowski C, Katz I, Doyle S, Smith BD, Kellner C, Bernstein HJ, Bachman DL, Knopman DS, Deinard S, Langley L, Bridges S, Margolin RA, Burger MC, Wiser SL, Crenshaw C, Morris JC, Rubin EH, Coats MA, Reyes PF, Bentz C, Doyle LL, Rymer MM, Bettinger IE, Laubinger MP, Sadowsky CH, Martinez W, Zuniga J, Stone R, Winner P, Mate L, Lessard C, Schneider L, Pawluczyk S, Smith WT, Losk SN, Marambe L, Solomon PR, Pendlebury WW, Grocciaellison ME, Edwards KR, Taylor J, Calabrese VP, Harkins SW, Thein SG, Dewar JA, Williams G, Drennan C, et al. (1994) A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. J Am Med Assoc 271: 985-991
27. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34: 939-944
28. Maltby N, Broe GA, Creasey H, Jorm AF, Christensen H, Brooks WS (1994) Efficacy of tacrine and lecithin in mild to moderate Alzheimer's disease: double blind trial. Br Med J 308: 879-883
29. Miller E (1975) Impaired recall and the memory disturbance in presenile dementia. Br J Clin Psychol 14: 73-79
30. 99mTc-Exametazime in anterior cingulate cortex in Korsakoff's psychosis. Psychol Med 24: 53-61
31. Montaldi D, Brooks DN, McColl JH, Wyper D, Patterson J, Barron E, McCulloch J (1990) Measurements of regional cerebral blood flow and cognitive performance in Alzheimer's disease. J Neurol Neurosurg Psychiatr 53: 33-38
32. Neirinckz RD, Canning LR, Piper IM, Nowotnik DP, Pickett RD, Holmes RA, Volkert WA, Forster AM, Weisner PS, Marriott JA, Chaplin SB (1987) Technetium-99m D, 1-HMPAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion. J Nucl Med 28: 191-202
33. Nelson HE, O'Connell S (1978) Dementia: the estimation of premorbid intelligence levels using the New Adult Reading Test. Cortex 14: 234-244
34. Nissen MJ, Knopman DS, Schacter DL (1987) Neurochemical dissociation of memory systems. Neurology 37: 789-794
35. O'Brien JT, Eagger S, Syed GMS, Sahakian BJ, Levy R (1992a) A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease. J Neurol Neurosurg Psychiatr 55: 1182-1187
36. O'Brien JT, Syed GM, Levy R (1992b) The effects of tacrine on regional cerebral blood flow in Alzheimer's disease. Int J Geriatr Psychiatr 7: 835-838
37. Philpot MP, Costa DC, Burns A, Levy R, Ell PJ (1991) Single photon emission tomography in Alzheimer's disease. A longitudinal study of changes in relative regional cerebral blood flow. Int J Geriatr Psychiatr 6: 767-774
38. Riddle W, O'Carroll RE, Dougall N, Van Beck M, Murray C, Curran J, Ebmeier KP, Goodwin GM (1993) A single photon emission computerised tomography study of regional brain function underlying verbal memory in patients with Alzheimer-type dementia. Br J Psychiatr 163: 166-172
39. Roth M, Tym E, Mountjoy CQ, Huppert FA, Hendrie H, Verma S, Goddard R (1986) CAMDEX A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatr 149: 698-709
40. Scremin OU, Allen K, Torres C, Scremin E (1988) Physostigmine enhances blood flow-metabolism ratio in neocortex. Neuropsychopharmacology 1: 297-303
41. Sunderland T, Tariot PN, Weingartner H, Murphy DL, Newhouse PA, Mueller EA, Cohen RM (1986) Pharmacologic modelling of Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatr 10: 599-610
42. Talairach J, Zilkha G, Tournoux P, Prosalentis A, Bordas-Ferrier M, Covello L, Iacob M, Mempel E (1988) Atlas d'Anatomie Stereotactique du Telencephale. Masson, Paris
43. Wilson BA, Cockburn JM, Baddeley AD, Hiorns R (1989) The development and validation of a test battery for detecting and monitoring everyday memory problems. J Clin Exp Neuropsychol 11: 855-870